Search Within

Genitourinary Oncology Service

  1. "Kenneth Offit"
Formats
  1. Journal Article (55)
  2. Meeting Abstract (54)
  3. Research Letter (2)
  4. Correspondence (1)
  5. Review (1)
Groups
  1. Clinical Genetics Service (113)
  2. Department of Medicine (113)
  3. GSK Faculty (113)
  4. Population Sciences Research Program (113)
  5. Solid Tumor Oncology Division (113)
  6. Survivorship Research (113)

More Groups

People
  1. Kenneth Offit (113)
  2. Zsofia Stadler (78)
  3. Diana Mandelker (64)
  4. Vijai Joseph (61)
  5. Yelena Kemel (61)
  6. Mark Robson (59)

More People

Years
  1. 2025 (5)
  2. 2024 (5)
  3. 2023 (13)
  4. 2022 (12)
  5. 2021 (17)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (41)
  2. Cancer Research (9)
  3. JCO Precision Oncology (6)
  4. Clinical Cancer Research (5)
  5. European Urology (4)
  6. Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (47)
  2. American Association for Cancer Research (18)
  3. Nature Publishing Group (11)
  4. Oxford University Press (6)
  5. American Medical Association (5)
  6. Elsevier Science, Inc. (5)

More Publishers

Results (113)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Germline landscape of high grade serous ovarian cancer across age groups: Is age just a number?
    Journal Article

    Sia, T. Y.; Moufarrij, S.; Milani, J.; Kane, S.; Zhou, Q.; Fong, C.; Khurram, A.; Kemel, Y. M.; Sheehan, M.; Latham, A.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • KEAP1 mutated renal cell carcinoma (RCC): Characterization of an emerging molecularly defined RCC subtype
    Meeting Abstract

    Carlo, M.; Chen, Y. B.; Knezevic, A.; Zong, G.; Bakouny, Z.; Kemel, Y.; Latham, A.; Liu, Y. L.; Shah, N. J.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with BRCA1/2 gene alterations (NePtune)
    Meeting Abstract

    Chen, Y. W.; Liu, L.; Cheng, Y.; Araneta, A.; Castano, N.; Gomez, J.; Ajmera, A.; Ye, H.; Runcie, K.; McHugh, D. J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases
    Journal Article

    Mitchell, J.; Camacho, N.; Shea, P.; Stopsack, K. H.; Joseph, V.; Burren, O. S.; Dhindsa, R. S.; Nag, A.; Berchuck, J. E.; O'Neill, A.; more...
    Nature Communications (2025)

    Fulltext@MSK | Save
  • Germline DNA damage repair variants and prognosis of patients with high-risk or metastatic prostate cancer
    Journal Article

    Stopsack, K. H.; Vijai, J.; Conry, M.; Berchuck, J. E.; Kemel, Y.; Vasselman, S. E.; Freeman, D. A.; Lee, G. S. M.; Mandelker, D.; Solit, D. B.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Characterising the contribution of rare protein-coding variants to prostate cancer risk and severity in 36,866 cases
    Meeting Abstract

    Mitchell, J.; Camacho, N.; Shea, P. R.; Stopsack, K.; Joseph, V.; Burren, O.; Penney, K.; Berchuck, J.; Wang, Q. L.; Goldstein, D.; more...
    European Journal of Human Genetics (2024)

    Fulltext@MSK | Save
  • Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings
    Research Letter

    Ceyhan-Birsoy, O.; Fiala, E.; Rana, S.; Sheehan, M.; Kennedy, J.; Yelskaya, Z.; Rai, V.; Li, Y.; Yang, C.; Wong, D.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with BRCA1/2 gene alterations (NePtune)
    Meeting Abstract

    McKay, R. R.; Liu, L.; Pu, M.; Araneta, A.; Wang, L.; Castano, N.; Gomez, J.; Ajmera, A.; Ye, H.; Pili, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with BRCA1/2 gene alterations (NePtune)
    Meeting Abstract

    McKay, R. R.; Liu, L.; Pu, M.; Araneta, A.; Yuen, K. L.; Gomez, J.; Castano, N.; Ajmera, A.; Ye, H.; Pili, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Benign splenic lesions in BAP1-tumor predisposition syndrome: A case series
    Journal Article

    Miranda, J.; Dave, P.; Kemel, Y.; Sheikh, R.; Zong, G.; Calderon, L. P.; Will, M.; Liu, Y. L.; Walsh, M.; Stadler, Z. K.; more...
    European Journal of Human Genetics (2024)

    Fulltext@MSK | Save